Hero area_1870x855

Greater Copenhagen
Microbiome Summit 2021

22 April
Online
SIGN UP

You’re invited to the Greater Copenhagen Microbiome Summit 2021

Join the Greater Copenhagen Microbiome Summit for the latest scientific trends and insights within the microbiome field from companies like BioGaia, Chr. Hansen, Ferring and Novozymes as well as academic experts.

The Greater Copenhagen Microbiome Summit offers a digital venue for bringing together microbiome scientists and companies to define the state of microbiome research and opportunities for collaborations in this emerging multidisciplinary field of science. The event will provide unique collaboration and business opportunities with both local and international stakeholders.

Key themes to be addressed in the programme:

• Antimicrobial resistance and the microbiome
• Immune health and the microbiome in the new normal
• Interconnected microbiomes - from oral health to the systemic effects
• Microbiome, animal health and bio agriculture

The Greater Copenhagen Microbiome Summit is initiated by the Greater Copenhagen Microbiome Signature Project and its partners Medicon Valley Alliance, Copenhagen Capacity and Invest in Skåne. The project aims to position Medicon Valley, the life science cluster of the Greater Copenhagen region, as the most competitive and vital life science cluster in northern Europe.

Practical information

Date: Thursday 22 April 2021
Time: 9.00 - 17:00 CET
Venue: This is a digital event, a link will be provided upon registration

Contact information
If you have any questions regarding the event, please do not hesitate to contact Sarah Lidé at sl@mva.org




Microbiome logo colour final

Themes & Speakers

arrow_white (1)

 

IMMUNE HEALTH & THE MICROBIOME IN THE NEW NORMAL

Globally we are living in unprecedented new times where the focus on infections and immune health has never been stronger.
The microbiome and intimate links to the immune system as they both develop from birth and how nutrition
and other factors profoundly affect our immune health throughout life will be discussed.

INTERCONNECTED MICROBIOMES -
FROM ORAL HEALTH TO THE SYSTEMIC EFFECTS

The human body is home to trillions of microorganisms living in complex microbial communities developing symbiotic interactions with the host. Each body mucosal site harbours its own microbiome with a specific structure and composition. It is increasingly observed that microbiomes from diverse mucosal sites could be interconnected, either by sharing members of the same bacterial family or taxa, or by producing similar metabolites. In turn, probiotics, defined as live microorganisms which when administered in adequate amounts confer a health benefit into the host, could interact with the gut microbiome and have a strong impact on the oral microbiome as well. During this session we will address the role of probiotics in oral health and discuss their potential impact on systemic diseases.

MICROBIOME, ANIMAL HEALTH AND BIO AGRICULTURE

There has been extensive and global research efforts in the past decade engaging in the study of microbial communities and their important relationship with higher organisms and large ecosystems (air, soil and oceans). Studies have revealed that a host’s or an ecosystem’s microbiome plays an essential role in health and disease/imbalance.

In this session we will take a deeper look at how researching the microbiome of living systems can generate new understanding of how microbiomes affect health and performance of especially animals and plants, and how that can lead to new bioindustrial solutions for animal health and bioagriculture.

ANTI-MICROBIAL RESISTANCE AND THE MICROBIOME

A growing number of bacteria are becoming resistant to common antibiotics making antimicrobial resistance a global health concern of increasing magnitude. This session will zoom in on the microbiome as a potential tool and target in the effort to address antimicrobial resistance.

Microbiome_background_image

PROGRAMME

To be updated on a continuous basis

9:45
Immune health & the microbiome in the new normal

Chairperson 

Adam Baker, Ph.D., Director of Science, Human Health Innovation, Chr. Hansen

Presentations

Impact of dietary factors and ingested bacteria on gut microbiota and immune functions
Åsa Håkansson, Associate Professor in Food Hygiene, Department of Food Technology, Engineering and Nutrition, Lund University

The role of the early life microbiome in development of asthma and allergy
Jakob Stokholm, MD, Ph.D., COPSAC and University of Copenhagen

What triggers and promotes celiac disease and can we prevent it? Lessons learnt from observational birth cohort studies
Daniel Agardh, Adjunct Professor, Diabetes and Celiac Unit, EXODIAB, Lund University

Discussion & Q&A

10:55
BREAK & NETWORKING
11:15
Interconnected microbiomes – from oral health to the systemic effects

Chairperson

Gianfranco Grompone, Chief Scientific Officer, BioGaia

Presentations

The burden of oral diseases and the importance of maintaining a balanced oral microbiome
Svante Twetman, PhD, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen

Jakob Axelsson, Research Manager, BioGaia

The mouth is an integral part of the human body: the oral health-systemic health connection
Wim Teughels, Professor and Vice-head, Periodontology, Department of Oral Health Sciences, KU Leuven, Belgium

Discussion & Q&A

12:25
LUNCH & NETWORKING
13:15
Microbiome, animal health and bio agriculture

Chairperson

Mads Bjørnvad, Senior Manager for Microbiomics and Microbe Discovery, Novozymes Denmark

Presentations

Applied hologenomics - should microbiome treatments be personalised?
Tom Gilbert, Director of the DNRF Center for Evolutionary Hologenomics, University of Copenhagen

How to study Microbiome Assisted Triticum Resilience In X-dimensions?
Lars Hestbjerg Hansen, Head of the Environmental Microbial Genomics group, Department of Plant and Environmental Sciences, University of Copenhagen

Discussion & Q&A

14:25
BREAK & NETWORKING
14:45
Anti-microbial resistance and the microbiome

Chairperson

Kristin Wannerberger, Director R&D Alliance Management, Ferring Pharmaceuticals

Presentations

Identification of anti-virulence compounds against Methicillin-resistant Staphylococcus aureus (MRSA) from host-adapted bacterial pathogens
Lars Jelsbak, Professor MSO, Department of Biotechnology and Biomedicine, DTU Bioengineering

Paul, Ross Director of APC Microbiome Institute, University College Cork, Ireland

Bacteriophages for Modulating Human Microbiome: The PhageBiotix™ and SuperBiotix™ Approaches and Their Potential Applications
Dr. Alexander “Sandro” Sulakvelidze, President and CEO of Intralytix

Discussion & Q&A

15:55
BREAK & NETWORKING
16:15
Panel discussion
16:45
Conclusion

 

 

Sign up here

Once you have signed up below, you will receive an email with a guide to complete your registration on our event platform Hopin.


Organisers

Invest in Skåne Copcap_logo MVA_Logo_300x225_v4